NCT02126709View on ClinicalTrials.gov

The Efficacy and Safety of 3% Povidone-Iodine in Acne Therapy

PHASE2UnknownINTERVENTIONAL

Enrollment

30

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2014

Conditions

Acne

Interventions

DRUG

Repigel

Repigel will be used as the intervention in the treatment group

Trial Locations (1)

119074

National University Hospital, Singapore

Sponsors

Collaborators (1)

Mundipharma Pte Ltd.

All Listed Sponsors

collaborator

Mundipharma Pte Ltd.

INDUSTRY

lead

National University Hospital, Singapore

OTHER